These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 30105697)
21. Drugs for hypertension. Med Lett Drugs Ther; 1977 Mar; 19(5):21-4. PubMed ID: 840157 [No Abstract] [Full Text] [Related]
22. Drugs used in the treatment of hypertension. Finnerty FA Mod Concepts Cardiovasc Dis; 1973 Jul; 42(7):33-6. PubMed ID: 4786758 [No Abstract] [Full Text] [Related]
23. Spironolactone in hypertensive patients. Oligemic and antihypertensive effects. GEORGOPOULOS AJ; DUSTAN H; PAGE IH Arch Intern Med; 1961 Sep; 108():389-92. PubMed ID: 13704490 [No Abstract] [Full Text] [Related]
24. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Mahmud A; Mahgoub M; Hall M; Feely J Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838 [TBL] [Abstract][Full Text] [Related]
26. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial. Oxlund CS; Henriksen JE; Tarnow L; Schousboe K; Gram J; Jacobsen IA J Hypertens; 2013 Oct; 31(10):2094-102. PubMed ID: 24107738 [TBL] [Abstract][Full Text] [Related]
27. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT)--study protocol. Vaclavik J; Sedlak R; Plachy M; Navratil K; Plasek J; Husar R; Kocianova E; Taborsky M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Jun; 155(2):143-8. PubMed ID: 21804623 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Nishizaka MK; Zaman MA; Calhoun DA Am J Hypertens; 2003 Nov; 16(11 Pt 1):925-30. PubMed ID: 14573330 [TBL] [Abstract][Full Text] [Related]
29. [MEDICAL TREATMENT OF PERMANENT ARTERIAL HYPERTENSION IN CHILDREN. (CRITICAL STUDY OF 24 CASES)]. MARIE J; ROYER P; GABILAN JC; VANDEVOORDE J Ann Pediatr (Paris); 1965 Apr; 12():251-62. PubMed ID: 14348171 [No Abstract] [Full Text] [Related]
30. A meta-analysis of add-on use of spironolactone in patients with resistant hypertension. Zhao D; Liu H; Dong P; Zhao J Int J Cardiol; 2017 Apr; 233():113-117. PubMed ID: 28089457 [TBL] [Abstract][Full Text] [Related]
31. Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Yang L; Zhang H; Cai M; Zou Y; Jiang X; Song L; Liang E; Bian J; Wu H; Hui R Clin Exp Hypertens; 2016; 38(5):464-8. PubMed ID: 27367159 [TBL] [Abstract][Full Text] [Related]
32. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension. Vaclavik J; Sedlak R; Jarkovsky J; Kocianova E; Taborsky M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):50-5. PubMed ID: 23128822 [TBL] [Abstract][Full Text] [Related]
33. Older blood pressure medications-do they still have a place? Slim HB; Black HR; Thompson PD Am J Cardiol; 2011 Jul; 108(2):308-16. PubMed ID: 21550576 [TBL] [Abstract][Full Text] [Related]
34. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989 [TBL] [Abstract][Full Text] [Related]
35. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441 [TBL] [Abstract][Full Text] [Related]
36. [PRELIMINARY NOTE CONCERNING THE DRUG ASSOCIATION OF A DIURETIC SULFONAMIDE AND A SPIROLACTONE IN THE TREATMENT OF PERMANENT ARTERIAL HYPERTENSION]. KLEPPING C; BENOIT JP Lyon Med; 1964 Nov; 212():1145-56. PubMed ID: 14233309 [No Abstract] [Full Text] [Related]
37. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077 [TBL] [Abstract][Full Text] [Related]
38. CURRENT VIEWS ON THE ETIOLOGY AND TREATMENT OF HYPERTENSION. MENDLOWITZ M; BALDWIN DS; KRAMER ML; GOLFINOS A; LARAGH JH; KWIT NT J Am Geriatr Soc; 1964 Mar; 12():239-44. PubMed ID: 14132409 [No Abstract] [Full Text] [Related]
39. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy? Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266 [TBL] [Abstract][Full Text] [Related]
40. The effect of low-dose spironolactone on resistant hypertension. Engbaek M; Hjerrild M; Hallas J; Jacobsen IA J Am Soc Hypertens; 2010; 4(6):290-4. PubMed ID: 21130975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]